Efficacy of Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis in the North American Subgroup of Patients: Pooled Analysis of Four Phase 3 Studies

Lignende værker

• Efficacy of Secukinumab on Moderate-to-severe Plaque Psoriasis Affecting Different Body Regions: a Pooled Analysis of Four Phase 3 Studies
  af: Menter, Alan, et al.
  Udgivet: (2016)
• Efficacy of Secukinumab for Moderate-to-Severe Head and Neck Psoriasis Over 52 Weeks: Pooled Analysis of Four Phase 3 Studies
  af: Kircik, Leon, et al.
  Udgivet: (2016)
• Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials
  af: Adsit, Sandra, et al.
  Udgivet: (2017)
• Erratum to: Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials
  af: Adsit, Sandra, et al.
  Udgivet: (2017)
• Population Pharmacokinetic Modeling of Secukinumab in Patients With Moderate to Severe Psoriasis
  af: Bruin, Gerard, et al.
  Udgivet: (2017)